​

Sionna Therapeutics (SION) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

SION Stock Forecast

Sionna Therapeutics (SION) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $54.00, with a high of $58.00 and a low of $50.00. This represents a 49.79% increase from the last price of $36.05.

SION Stock Rating

Sionna Therapeutics stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (71.43%), 1 Hold (14.29%), 1 Sell (14.29%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 1 5 Strong Sell Sell Hold Buy Strong Buy

SION Price Target Upside V Benchmarks

TypeNameUpside
StockSionna Therapeutics49.79%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts117
Avg Price Target$55.00$55.00$43.86
Last Closing Price$36.05$36.05$36.05
Upside/Downside52.57%52.57%21.66%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26181-111
May, 2618--110
Apr, 2618--110
Mar, 2618--110
Feb, 26-7--18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 18, 2026Paul MatteisStifel Nicolaus$55.00$40.2236.75%52.57%
Mar 02, 2026Yatin SunejaGuggenheim$50.00$34.4045.35%38.70%
Jan 07, 2026Kambiz YazdiBTIG$58.00$37.2255.83%60.89%
Jan 05, 2026Chris RaymondRaymond James$53.00$39.2135.17%47.02%
Dec 01, 2025RBC Capital$24.00$43.57-44.92%-33.43%
Sep 03, 2025Brian AbrahamsRBC Capital$22.00$26.19-16.00%-38.97%
Sep 02, 2025Raymond James$45.00$25.3977.24%24.83%
Mar 04, 2025Guggenheim$45.00$14.80204.05%24.83%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 02, 2026UBSBuyBuyhold
Feb 24, 2026CitigroupOutperforminitialise
Jan 07, 2026BTIGBuyBuyhold
Jan 05, 2026Raymond JamesStrong BuyStrong Buyhold
Dec 01, 2025RBC CapitalSector PerformUnderperformdowngrade
Nov 05, 2025Raymond JamesStrong BuyStrong Buyhold
Sep 03, 2025RBC CapitalSector Performinitialise
Sep 02, 2025Raymond JamesStrong Buyinitialise
Mar 04, 2025GuggenheimBuyinitialise

Financial Forecast

EPS Forecast

$-6 $-5 $-4 $-3 $-2 $-1 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-1.40$-1.88----
Avg Forecast$-5.26$-2.65$-2.87$-3.30$-3.59$-1.95
High Forecast$-5.26$-2.58$-2.54$-2.67$-3.59$-1.95
Low Forecast$-5.26$-2.72$-3.36$-3.93$-3.59$-1.95
Surprise %-73.38%-29.06%----

Revenue Forecast

Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported------
Avg Forecast-----$64.00M
High Forecast-----$64.00M
Low Forecast-----$64.00M
Surprise %------

Net Income Forecast

$-250M $-210M $-170M $-130M $-90M $-50M Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-61.69M$-75.27M----
Avg Forecast$-223.40M$-112.48M$-114.95M$-143.05M$-152.16M$-82.77M
High Forecast$-223.40M$-109.59M$-107.92M$-113.22M$-152.16M$-82.77M
Low Forecast$-223.40M$-115.36M$-142.77M$-166.92M$-152.16M$-82.77M
Surprise %-72.39%-33.08%----

SION Forecast FAQ

Is Sionna Therapeutics stock a buy?

Sionna Therapeutics stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Sionna Therapeutics is a favorable investment for most analysts.

What is Sionna Therapeutics's price target?

Sionna Therapeutics's price target, set by 7 Wall Street analysts, averages $54 over the next 12 months. The price target range spans from $50 at the low end to $58 at the high end, suggesting a potential 49.79% change from the previous closing price of $36.05.

How does Sionna Therapeutics stock forecast compare to its benchmarks?

Sionna Therapeutics's stock forecast shows a 49.79% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Sionna Therapeutics over the past three months?

  • June 2026: 9.09% Strong Buy, 72.73% Buy, 9.09% Hold, 0% Sell, 9.09% Strong Sell.
  • May 2026: 10.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 10.00% Strong Sell.
  • April 2026: 10.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 10.00% Strong Sell.

What is Sionna Therapeutics’s EPS forecast?

Sionna Therapeutics's average annual EPS forecast for its fiscal year ending in December 2026 is $-2.87, marking a 52.66% increase from the reported $-1.88 in 2025. Estimates for the following years are $-3.3 in 2027, $-3.59 in 2028, and $-1.95 in 2029.

What is Sionna Therapeutics’s revenue forecast?

Sionna Therapeutics's average annual revenue forecast for its fiscal year ending in December 2026 is $0, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $0, followed by $0 for 2028, and $64M for 2029.

What is Sionna Therapeutics’s net income forecast?

Sionna Therapeutics's net income forecast for the fiscal year ending in December 2026 stands at $-115M, representing an 52.72% increase from the reported $-75.268M in 2025. Projections indicate $-143M in 2027, $-152M in 2028, and $-82.767M in 2029.